Fulcrum Therapeutics (FULC) Treasury Shares: 2019-2025
Historic Treasury Shares for Fulcrum Therapeutics (FULC) over the last 6 years, with Sep 2025 value amounting to $69.5 million.
- Fulcrum Therapeutics' Treasury Shares rose 97577.75% to $69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.5 million, marking a year-over-year increase of 97577.75%. This contributed to the annual value of $43,072 for FY2024, which is 42.58% down from last year.
- As of Q3 2025, Fulcrum Therapeutics' Treasury Shares stood at $69.5 million, which was down 1.67% from $70.7 million recorded in Q2 2025.
- Fulcrum Therapeutics' Treasury Shares' 5-year high stood at $70.7 million during Q2 2025, with a 5-year trough of $536 in Q3 2021.
- Over the past 3 years, Fulcrum Therapeutics' median Treasury Shares value was $86,495 (recorded in 2023), while the average stood at $14.1 million.
- Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 88.30% in 2021, then skyrocketed by 97,577.75% in 2025.
- Fulcrum Therapeutics' Treasury Shares (Quarterly) stood at $536 in 2021, then reached $76,718 in 2022, then decreased by 2.22% to $75,017 in 2023, then plummeted by 42.58% to $43,072 in 2024, then skyrocketed by 97,577.75% to $69.5 million in 2025.
- Its last three reported values are $69.5 million in Q3 2025, $70.7 million for Q2 2025, and $88,048 during Q1 2025.